Skip to content

Acupuncture for insomnia with short sleep duration: a randomized controlled trial

Acupuncture for insomnia with short sleep duration: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023473
Enrollment
Unknown
Registered
2019-05-30
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

Control group:sham acupuncture

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18 to 65 years, male or female; (2) Compliance with the diagnostic criteria for chronic insomnia in ICSD-3; (3) Stable administration of sedative-hypnotic drugs for more than 3 months before entering the study or not taken such drugs, and did not participate in other insomnia research; (4) PSQI> 5 points, ISI> 14 points, BAI< 45 points and BDI = 28 points; (5) Never received acupuncture treatment; (6) Voluntarily participated in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Severe hepatic and renal function damage, as well as hematologic diseases and respiratory diseases and diagnosis of the mental disorders according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) [34]; (2) Semi-structured clinical interviews determined subjects as other sleep disorders rather than primary insomnia; (3) Subjects with infectious diseases such as infectious hepatitis, tuberculosis, AIDS, syphilis,etc.; (4) Severe digestive system diseases and severe malnutrition; (5) Pregnant or lactating women; (6) Subjects with severe trauma and not cured or other subjects not suitable for acupuncture, such as: allergic constitution, patients with severe dermatosis; (7) Participated in other clinical trials in the last 3 months.

Design outcomes

Primary

MeasureTime frame
PSQI scale;ISI scale;

Secondary

MeasureTime frame
ACT;BAI scale;BDI scale;FSS scale;

Countries

China

Contacts

Public ContactYunfei Chen

Laboratory Center of Medicine, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

icyf1968@163.com+86 18930568221

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026